Clarity Pharmaceuticals Ltd

NEW
FRA:1F4 (Australia)  
€ 1.48 -0.080 (-5.13%) Aug 21
At Loss
P/B:
3.96
Market Cap:
€ 563.54M ($ 658.30M)
Enterprise V:
€ 425.74M ($ 497.33M)
Volume:
0
Avg Vol (2M):
3.86K
Trade In:

Clarity Pharmaceuticals Ltd (FRA:1F4) Dividend

Clarity Pharmaceuticals Ltd (FRA:1F4) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -7.5%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:1F4 Dividend

Does Clarity Pharmaceuticals Ltd (FRA:1F4) pay a dividend?

Clarity Pharmaceuticals Ltd (FRA:1F4) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Clarity Pharmaceuticals Ltd pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Clarity Pharmaceuticals Ltd has returned capital to shareholders via buybacks at a rate of -7.5% over the past 3 years.

What are dividend-paying alternatives to Clarity Pharmaceuticals Ltd?

For dividend-paying alternatives in Clarity Pharmaceuticals Ltd's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.